"Biopure analysis" Essays and Research Papers

Sort By:
Satisfactory Essays
Good Essays
Better Essays
Powerful Essays
Best Essays
Page 1 of 50 - About 500 Essays
  • Satisfactory Essays

    Biopure

    • 386 Words
    • 2 Pages

    Biopure Overview: * Biopure Corporation is a privately owned biopharmaceutical firm specializing in the ultrapurification of proteins for human and veterinary use. * It is one of the three legitimate contenders in the emerging field of “blood substitutes”. * Their products Oxyglobin and Hemopure are blood substitutes for the animal and the human market respectively. * Oxyglobin has just received final FDA approval for commercial release and is ready for launch. Hemopure would soon

    Premium Blood Blood transfusion

    • 386 Words
    • 2 Pages
    Satisfactory Essays
  • Better Essays

    Q1. Should Biopure launch Oxyglobin? Why? Support your arguments with quantitative analysis (ie. calc. of market potential). We believe that Biopure should launch Oxyglobin now. First of all‚ the potential market demand is huge. While current annual demand is 354‚750 units (95% primary care practices x 17 units canine blood/primary care practice + 5% specialty care practices x 150 units canine blood/specialty care practice)i accounting for only 2.5% of the cases‚ potential market demand including

    Premium Blood Marketing Blood transfusion

    • 1310 Words
    • 6 Pages
    Better Essays
  • Good Essays

    Biopure Case Group1 SecB

    • 977 Words
    • 36 Pages

    Biopure  Case  Analysis                     Group  1‚  Section  B     The  analysis  deals  with  the  Target  Markets  and  their  different  segments  for  the  two  products  of   Biopure  Corporation‚  namely  Oxyglobin  and  Hemopure.     Oxyglobin   -­‐ Used  as  a  substitute  for  blood  transfusion  in  dogs.   -­‐ Target   market   is  30%   of   all   the

    Premium

    • 977 Words
    • 36 Pages
    Good Essays
  • Satisfactory Essays

    Carl Rausch President and CEO of Biopure Corporation FROM: Hoang‚ Ann and Mishra‚ Ravi RE: Whether and When to Launch Oxyglobin Biopure needs to determine the best course of action to launch two new products‚ Oxyglobin a blood substitute for the veterinary market and Hemopure a blood substitute for the human market. Oxyglobin has been approved for commercial use and is ready for launch while Hemopure is expected to be FDA approved within two years. Biopure needs to decide whether and when

    Premium Blood Blood transfusion Marketing

    • 1016 Words
    • 5 Pages
    Satisfactory Essays
  • Good Essays

    BioPure Analysis

    • 503 Words
    • 2 Pages

    I will examine the challenges faced by Biopure in sequencing the release of 2 drugs. One ‚Oxyglobin‚ is ready for the Veterinary Market‚ and the other‚ Hemopure‚ whose success could rely on the brand management of the former. I will look at issues related to the success of the company and make the recommendation to launch Oxyglobin now. Currently Biopure creates blood products for two markets‚ human and veterinary. While Oxyglobin is ready to release for the veterinary market‚ Hemopure is 2 years

    Premium Blood Blood transfusion

    • 503 Words
    • 2 Pages
    Good Essays
  • Satisfactory Essays

    marketing

    • 494 Words
    • 2 Pages

    Background Biopure Corporation a company founded in 1984 with the primary goal of developing a human blood substitute; a product that has oxygen-carrying property of blood without the harmful effects of donated blood. The company currently has two new products: Oxyglobin and Hemopure. Oxyglobin‚ blood substitute for the veterinary market and is ready for launch. Hemopure‚ another blood substitute but for the human market and it will take two years to launch the product; provided they get FDA approval

    Premium Blood Pricing

    • 494 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Biopure case analysis

    • 611 Words
    • 3 Pages

    Carl Rausch FROM: RE: Biopure Market Analysis DATE: Oct 31‚ 2013 Deciding whether to go into the veterinary blood market now or not is a critical decision to Biopure right now. To maximize the profits and capture the valuable opportunity‚ Biopure is recommended to step into the marketplace and be the first to offer Oxyglobin‚ blood substitute for the animal market. Pioneering the veterinary blood market is expected to generate gross profits of $26.55 miilion to Biopure annually‚ with a breakeven

    Premium Blood transfusion Blood

    • 611 Words
    • 3 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Biopure

    • 1060 Words
    • 5 Pages

    Brief Overview: Biopure has two new products namely Oxyglobin and Hemopure. Oxyglobin is a first of its kind‚ new blood substitute for the veterinary market and has passed all the tests and is ready for consumer use. Hemopure is another such blood substitute for the human market and it will take a minimum of two years to launch the product from now. There is a concern about creating an unrealistic price expectation for Hemopure by marketing Oxyglobin before Hemopure. Whereas another point of view

    Free Blood Blood transfusion

    • 1060 Words
    • 5 Pages
    Satisfactory Essays
  • Good Essays

    Oxyglobin Case

    • 621 Words
    • 3 Pages

    network would require a commission to the distributor of 20% to 30% of the selling price. At $200 and 300‚000 units‚ this would be between $9‚000‚000 and $13‚500‚000. It is more cost effective for Biopure to sell directly to the veterinary practices. This manufacturer direct model (Exhibit 4) will require Biopure to recruit and maintain a sales force of approximately 10 employees (at an estimate total cost of $100‚000 per) and carries a $10-$15 distribution cost per unit. With 750 emergency practices‚

    Premium Blood Price Marketing

    • 621 Words
    • 3 Pages
    Good Essays
  • Satisfactory Essays

    Biopure Case Analysis

    • 1200 Words
    • 5 Pages

    Brief Overview: Biopure has two new products namely Oxyglobin and Hemopure. Oxyglobin is a first of its kind‚ new blood substitute for the veterinary market and has passed all the tests and is ready for consumer use. Hemopure is another such blood substitute for the human market and it will take a minimum of two years to launch the product from now. There is a concern about creating an unrealistic price expectation for Hemopure by marketing Oxyglobin before Hemopure. Whereas another point of view

    Free Blood Blood transfusion

    • 1200 Words
    • 5 Pages
    Satisfactory Essays
Previous
Page 1 2 3 4 5 6 7 8 9 50